<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Details for gene set BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN[GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='keyValTable'><table cols='2' border='0'><th class='keyValTable'></th><th class='keyValTable'></th><tr><td>Dataset</td><td>GSEA_formatted_normalized_counts_collapsed_to_symbols.sample_info.cls.txt<br>#nonresponse_versus_response.sample_info.cls.txt<br>#nonresponse_versus_response_repos</td></tr><tr><td>Phenotype</td><td>sample_info.cls.txt#nonresponse_versus_response_repos</td></tr><tr><td>Upregulated in class</td><td>1</td></tr><tr><td>GeneSet</td><td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN</td></tr><tr><td>Enrichment Score (ES)</td><td>-0.5002227</td></tr><tr><td>Normalized Enrichment Score (NES)</td><td>-1.7287009</td></tr><tr><td>Nominal p-value</td><td>0.009541985</td></tr><tr><td>FDR q-value</td><td>1.0</td></tr><tr><td>FWER p-Value</td><td>0.947</td></tr><caption class='table'>Table: GSEA Results Summary</caption></table></div><br><div class='image'><img name='enplot_BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN' src='enplot_BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN_99.png'><br><br><caption>Fig 1: Enrichment plot: BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN &nbsp&nbsp <br> Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List</caption></div><br><div class='richTable'><table cols='7' border='1'><th class='richTable'></th><th class='richTable'>SYMBOL</th><th class='richTable'>TITLE</th><th class='richTable'>RANK IN GENE LIST</th><th class='richTable'>RANK METRIC SCORE</th><th class='richTable'>RUNNING ES</th><th class='richTable'>CORE ENRICHMENT</th><tr><td class='lessen'>1</td><td><a href='https://ensembl.org/Search/Results?q=IGLV2-14'>IGLV2-14</a></td><td>immunoglobulin lambda variable 2-14 [Source:HGNC Symbol;Acc:HGNC:5888]</td><td>4451</td><td>0.253</td><td>-0.0873</td><td>No</td></tr><tr><td class='lessen'>2</td><td><a href='https://ensembl.org/Search/Results?q=COA1'>COA1</a></td><td>cytochrome c oxidase assembly factor 1 homolog [Source:HGNC Symbol;Acc:HGNC:21868]</td><td>7028</td><td>0.192</td><td>-0.1304</td><td>No</td></tr><tr><td class='lessen'>3</td><td><a href='https://ensembl.org/Search/Results?q=FSCN2'>FSCN2</a></td><td>fascin actin-bundling protein 2, retinal [Source:HGNC Symbol;Acc:HGNC:3960]</td><td>7139</td><td>0.190</td><td>-0.1025</td><td>No</td></tr><tr><td class='lessen'>4</td><td><a href='https://ensembl.org/Search/Results?q=SRSF8'>SRSF8</a></td><td>serine and arginine rich splicing factor 8 [Source:HGNC Symbol;Acc:HGNC:16988]</td><td>7169</td><td>0.189</td><td>-0.0725</td><td>No</td></tr><tr><td class='lessen'>5</td><td><a href='https://ensembl.org/Search/Results?q=CDH2'>CDH2</a></td><td>cadherin 2 [Source:HGNC Symbol;Acc:HGNC:1759]</td><td>11662</td><td>0.102</td><td>-0.1858</td><td>No</td></tr><tr><td class='lessen'>6</td><td><a href='https://ensembl.org/Search/Results?q=MRPL28'>MRPL28</a></td><td>mitochondrial ribosomal protein L28 [Source:HGNC Symbol;Acc:HGNC:14484]</td><td>11899</td><td>0.097</td><td>-0.1768</td><td>No</td></tr><tr><td class='lessen'>7</td><td><a href='https://ensembl.org/Search/Results?q=SRSF6'>SRSF6</a></td><td>serine and arginine rich splicing factor 6 [Source:HGNC Symbol;Acc:HGNC:10788]</td><td>13760</td><td>0.061</td><td>-0.2206</td><td>No</td></tr><tr><td class='lessen'>8</td><td><a href='https://ensembl.org/Search/Results?q=TNFRSF10B'>TNFRSF10B</a></td><td>TNF receptor superfamily member 10b [Source:HGNC Symbol;Acc:HGNC:11905]</td><td>13908</td><td>0.058</td><td>-0.2155</td><td>No</td></tr><tr><td class='lessen'>9</td><td><a href='https://ensembl.org/Search/Results?q=DDX17'>DDX17</a></td><td>DEAD-box helicase 17 [Source:HGNC Symbol;Acc:HGNC:2740]</td><td>14043</td><td>0.055</td><td>-0.2104</td><td>No</td></tr><tr><td class='lessen'>10</td><td><a href='https://ensembl.org/Search/Results?q=PIM2'>PIM2</a></td><td>Pim-2 proto-oncogene, serine/threonine kinase [Source:HGNC Symbol;Acc:HGNC:8987]</td><td>14826</td><td>0.039</td><td>-0.2266</td><td>No</td></tr><tr><td class='lessen'>11</td><td><a href='https://ensembl.org/Search/Results?q=NKTR'>NKTR</a></td><td>natural killer cell triggering receptor [Source:HGNC Symbol;Acc:HGNC:7833]</td><td>15686</td><td>0.023</td><td>-0.2476</td><td>No</td></tr><tr><td class='lessen'>12</td><td><a href='https://ensembl.org/Search/Results?q=CCNG2'>CCNG2</a></td><td>cyclin G2 [Source:HGNC Symbol;Acc:HGNC:1593]</td><td>16925</td><td>0.000</td><td>-0.2834</td><td>No</td></tr><tr><td class='lessen'>13</td><td><a href='https://ensembl.org/Search/Results?q=NR2C1'>NR2C1</a></td><td>nuclear receptor subfamily 2 group C member 1 [Source:HGNC Symbol;Acc:HGNC:7971]</td><td>17320</td><td>-0.007</td><td>-0.2936</td><td>No</td></tr><tr><td class='lessen'>14</td><td><a href='https://ensembl.org/Search/Results?q=SEC62'>SEC62</a></td><td>SEC62 homolog, preprotein translocation factor [Source:HGNC Symbol;Acc:HGNC:11846]</td><td>18462</td><td>-0.029</td><td>-0.3219</td><td>No</td></tr><tr><td class='lessen'>15</td><td><a href='https://ensembl.org/Search/Results?q=BTN3A3'>BTN3A3</a></td><td>butyrophilin subfamily 3 member A3 [Source:HGNC Symbol;Acc:HGNC:1140]</td><td>19179</td><td>-0.043</td><td>-0.3355</td><td>No</td></tr><tr><td class='lessen'>16</td><td><a href='https://ensembl.org/Search/Results?q=SEC24A'>SEC24A</a></td><td>SEC24 homolog A, COPII coat complex component [Source:HGNC Symbol;Acc:HGNC:10703]</td><td>19407</td><td>-0.048</td><td>-0.3343</td><td>No</td></tr><tr><td class='lessen'>17</td><td><a href='https://ensembl.org/Search/Results?q=CCND1'>CCND1</a></td><td>cyclin D1 [Source:HGNC Symbol;Acc:HGNC:1582]</td><td>19734</td><td>-0.055</td><td>-0.3348</td><td>No</td></tr><tr><td class='lessen'>18</td><td><a href='https://ensembl.org/Search/Results?q=CD2AP'>CD2AP</a></td><td>CD2 associated protein [Source:HGNC Symbol;Acc:HGNC:14258]</td><td>22179</td><td>-0.102</td><td>-0.3887</td><td>No</td></tr><tr><td class='lessen'>19</td><td><a href='https://ensembl.org/Search/Results?q=HLA-DQB1'>HLA-DQB1</a></td><td>major histocompatibility complex, class II, DQ beta 1 [Source:HGNC Symbol;Acc:HGNC:4944]</td><td>22284</td><td>-0.104</td><td>-0.3746</td><td>No</td></tr><tr><td class='lessen'>20</td><td><a href='https://ensembl.org/Search/Results?q=MYB'>MYB</a></td><td>MYB proto-oncogene, transcription factor [Source:HGNC Symbol;Acc:HGNC:7545]</td><td>22299</td><td>-0.105</td><td>-0.3579</td><td>No</td></tr><tr><td class='lessen'>21</td><td><a href='https://ensembl.org/Search/Results?q=FBXO21'>FBXO21</a></td><td>F-box protein 21 [Source:HGNC Symbol;Acc:HGNC:13592]</td><td>23426</td><td>-0.124</td><td>-0.3701</td><td>No</td></tr><tr><td class='lessen'>22</td><td><a href='https://ensembl.org/Search/Results?q=PPT2'>PPT2</a></td><td>palmitoyl-protein thioesterase 2 [Source:HGNC Symbol;Acc:HGNC:9326]</td><td>24842</td><td>-0.148</td><td>-0.3868</td><td>No</td></tr><tr><td class='lessen'>23</td><td><a href='https://ensembl.org/Search/Results?q=TBC1D5'>TBC1D5</a></td><td>TBC1 domain family member 5 [Source:HGNC Symbol;Acc:HGNC:19166]</td><td>26312</td><td>-0.176</td><td>-0.4005</td><td>No</td></tr><tr><td class='lessen'>24</td><td><a href='https://ensembl.org/Search/Results?q=ACOX1'>ACOX1</a></td><td>acyl-CoA oxidase 1 [Source:HGNC Symbol;Acc:HGNC:119]</td><td>28776</td><td>-0.227</td><td>-0.4345</td><td>No</td></tr><tr><td class='lessen'>25</td><td><a href='https://ensembl.org/Search/Results?q=CDK8'>CDK8</a></td><td>cyclin dependent kinase 8 [Source:HGNC Symbol;Acc:HGNC:1779]</td><td>29850</td><td>-0.250</td><td>-0.4246</td><td>No</td></tr><tr><td class='lessen'>26</td><td><a href='https://ensembl.org/Search/Results?q=RXRB'>RXRB</a></td><td>retinoid X receptor beta [Source:HGNC Symbol;Acc:HGNC:10478]</td><td>32466</td><td>-0.321</td><td>-0.4477</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>27</td><td><a href='https://ensembl.org/Search/Results?q=CCNG1'>CCNG1</a></td><td>cyclin G1 [Source:HGNC Symbol;Acc:HGNC:1592]</td><td>32503</td><td>-0.322</td><td>-0.3959</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>28</td><td><a href='https://ensembl.org/Search/Results?q=VPS52'>VPS52</a></td><td>VPS52 subunit of GARP complex [Source:HGNC Symbol;Acc:HGNC:10518]</td><td>32998</td><td>-0.347</td><td>-0.3534</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>29</td><td><a href='https://ensembl.org/Search/Results?q=VTI1B'>VTI1B</a></td><td>vesicle transport through interaction with t-SNAREs 1B [Source:HGNC Symbol;Acc:HGNC:17793]</td><td>33285</td><td>-0.366</td><td>-0.3018</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>30</td><td><a href='https://ensembl.org/Search/Results?q=RGL2'>RGL2</a></td><td>ral guanine nucleotide dissociation stimulator like 2 [Source:HGNC Symbol;Acc:HGNC:9769]</td><td>33314</td><td>-0.368</td><td>-0.2424</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>31</td><td><a href='https://ensembl.org/Search/Results?q=ZFYVE26'>ZFYVE26</a></td><td>zinc finger FYVE-type containing 26 [Source:HGNC Symbol;Acc:HGNC:20761]</td><td>33947</td><td>-0.426</td><td>-0.1909</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>32</td><td><a href='https://ensembl.org/Search/Results?q=PREP'>PREP</a></td><td>prolyl endopeptidase [Source:HGNC Symbol;Acc:HGNC:9358]</td><td>34525</td><td>-0.601</td><td>-0.1091</td><td bgcolor='#CCFFCC'>Yes</td></tr><tr><td class='lessen'>33</td><td><a href='https://ensembl.org/Search/Results?q=DDR1'>DDR1</a></td><td>discoidin domain receptor tyrosine kinase 1 [Source:HGNC Symbol;Acc:HGNC:2730]</td><td>34564</td><td>-0.678</td><td>0.0008</td><td bgcolor='#CCFFCC'>Yes</td></tr><caption class='table'>Table: GSEA details&nbsp<a href='BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN.tsv'>[plain text format]</a></caption></table></div><br><div class='image'><img name='BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN' src='BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN_100.png'><br><br><caption>Fig 2: BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN &nbsp&nbsp <br> Blue-Pink O' Gram in the Space of the Analyzed GeneSet</caption></div><br><div class='image'><img name='gset_rnd_es_dist' src='gset_rnd_es_dist_101.png'><br><br><caption>Fig 3: BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN: Random ES distribution &nbsp&nbsp <br> Gene set null distribution of ES for <b>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN</b></caption></div><br></body></html>